NL-OMON21847尚未招募不适用
Pharmacogenetics Use For Further treatment Improvement in childre
Academic Medical Center (AMC)0 个研究点目标入组 310 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 310
研究概览
简要总结
Vijverberg SJ, Pijnenburg MW, Hövels AM, Koppelman GH, Maitland-van der Zee AH. The need for precision medicine clinical trials in childhood asthma: rationale and design of the PUFFIN trial. Pharmacogenomics. 2017;18(4):393-401.
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Between 6-18 years of age
- •- Doctor's diagnosis of asthma based on FEV1 reversibility >= 12% ever and/or bronchial hyperresponsiveness ever
排除标准
- •- Active smoking
- •- Congenital heart disease
研究者
相似试验
进行中（未招募）
1 期
Genotype-guided treatment of children with uncontrolled asthmaChildren with persistent uncontrolled asthmaEUCTR2017-004424-29-NLAcademic Medical Center25
进行中（未招募）
不适用
APPLICATION OF PHARMACOGENOMICS IN THE TREATMENT OF ELDERLY PATIENTS WITH ADVANCED COLORECTAL CANCER - PHARMACOGENOMICS IN THE ELDERLYELDERLY PATIENTS WITH METASTATIC COLORECTAL CANCERMedDRA version: 6.1Level: HLTClassification code 10010040EUCTR2006-004016-40-ITAZIENDA OSPEDALIERO UNIVERSITARIA OSPEDALI RIUNITI UMBERTO I - G.M.LANCISI - G.SALESI
招募中
1 期
Clinical Pharmacogenetic Study of Sorafenib in Egyptian Patients With Hepatocellular CarcinomaHepatocellular CarcinomaHCCNCT06527495Assiut University150
尚未招募
不适用
Clinical utility of genetic testing based treatment of depression in India as per recommendations of international guidelinesCTRI/2022/08/044982Indian Council of Medical Research
已完成
不适用
Pharmacogenetics Use For Further Treatment Improvement in childreNAsthma in ChildrenNCT03654508Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)102